SNYR — Synergy CHC Share Price
0.000.00%
Last trade - 00:00- $21.34m
- $48.16m
- $34.83m
- 31
- 96
- 44
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 3.66 | ||
| PEG Ratio (f) | 0.08 | ||
| EPS Growth (f) | 81.75% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.61 | ||
| EV to EBITDA | 8.11 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | 16.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 33.82 | 29.36 | 40.23 | 42.78 | 34.83 | 1.46 | 1.69 | -0.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +345.32 | -67.61 | +115.46 | +45 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Synergy CHC Corp. is a consumer healthcare and beauty company. The Company is the provider of consumer healthcare, beauty, and lifestyle products. The Company’s brand portfolio consists of FOCUSfactor and Flat Tummy. FOCUSfactor is a brain health supplement brand. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 29th, 2010
- Public Since
- November 8th, 2013
- No. of Shareholders
- 30
- No. of Employees
- 21
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 8,572,105
- Address
- 865 Spring St, WESTBROOK, 04092-3828
- Web
- https://synergychc.com/
- Phone
- +1 6159399004
- Auditors
- RBSM LLP
Upcoming Events for SNYR
Similar to SNYR
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Agriforce Growing Systems
NASDAQ Capital Market
Akari Therapeutics
NASDAQ Capital Market
Akebia Therapeutics
NASDAQ Capital Market
ASP Isotopes
NASDAQ Capital Market
FAQ
What is the Synergy CHC share price?
As of Today at 23:32 UTC, shares in Synergy CHC are trading at $2.49. This share price information is delayed by 15 minutes.
How has the Synergy CHC share price performed this year?
Shares in Synergy CHC last closed at $2.49 and the price had moved by +1992.44% over the past 365 days. In terms of relative price strength the Synergy CHC share price has outperformed the S&P500 Index by +1867.48% over the past year.
What are the analyst and broker recommendations for Synergy CHC?
The overall consensus recommendation for Synergy CHC is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Synergy CHC dividend yield?
Synergy CHC does not currently pay a dividend.
Does Synergy CHC pay a dividend?
Synergy CHC does not currently pay a dividend.
When does Synergy CHC next pay dividends?
Synergy CHC does not currently pay a dividend.
How do I buy Synergy CHC shares?
To buy shares in Synergy CHC you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Synergy CHC?
As of the previous close price of $2.49, shares in Synergy CHC had a market capitalisation of $21.34m.
Where are Synergy CHC shares listed?
Here are the trading details for Synergy CHC:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SNYR
What kind of share is Synergy CHC?
Based on an overall assessment of its quality, value and momentum Synergy CHC is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Synergy CHC share price forecast for 2025?
The analyst consensus target price for shares in Synergy CHC is $10.00. That is 301.61% above the last closing price of $2.49.
Analysts covering Synergy CHC currently have a consensus Earnings Per Share (EPS) forecast of $0.60 for the next financial year.
Find out moreWhat is the trend in the Synergy CHC share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Synergy CHC. Over the past six months, its share price has underperformed the S&P500 Index by -31.87%.
As of the last closing price of $2.49, shares in Synergy CHC were trading -16.5% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Synergy CHC PE Ratio?
The Synergy CHC PE ratio based on its reported earnings over the past 12 months is 3.66. The shares last closed at $2.49.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Synergy CHC?
Synergy CHC's management team is headed by:
- Jack Ross - CHM
- Stephen Fryer - DRC
- Paul SoRelle - DRC
- Gale Bensussen - IND